Vizgen

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of biomolecule profiling technology designed to bring new insight into biological systems and disease. Vizgen is based in Cambridge, MA and was founded in 2019. Its last reported valuation was $380 million in Apr 2022. It has raised $184 million across 6 recorded rounds; the latest was a $47.8 million early-stage round in Dec 2025.

Last reported valuation
$379.7M
Oct 2026
Priced at
—
Total raised
$184.2M
Last round
Early Stage VC
Dec 2025

Who backs Vizgen?

10 investors
InvestorType
ARCH Venture PartnersVenture capital
M VenturesVenture capital
Harvard UniversityOther
Sofina—
Tao Capital PartnersVenture capital
Pura Vida InvestmentsHedge fund
Novalis LifeSciencesAsset manager
Blue Water Life Science Fund—
David Walt—
Northpond Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Vizgen investors

10 investors are on record for Vizgen, including ARCH Venture Partners, M Ventures, Harvard University and Sofina. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 asset manager. The early-stage round in Dec 2025 drew 9 investors.

Free account
More of Vizgen with a free account
  • ·Watch Vizgen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Vizgen. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View